Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Mansoura University
Biologic lung volume reduction (BioLVR): it is a novel endobronchial approach, which uses a Biological agents aiming to reduce lung volume by blocking off the most emphysematous areas with a rapidly polymerizing sealant. The mechanism of action involves resorption atelectasis from airway occlusion, subsequent airspace inflammation, and then remodeling. This remodeling will lead to scarring that induces contraction of lung parenchyma and functional volume reduction can be expected within 6-8 weeks. Biological lung volume reduction occurs independent of the presence or absence of collateral ventilation.
Age
40–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Emphysema determined by HRCT of the chest with:
* .Persistent symptoms (i.e. a baseline Modified Medical Research Council dyspnea (MRC) score of \>2 despite medical therapy).
* FEV1 /FVC \< 70% and FEV1 20%-50 % (Sever and very sever airflow limitation according to GOLD 2013).
* Hyperinflation (total lung capacity (TLC) \> 110% pred and residual volume/total lung capacity (RV/TLC) \> 120% pred.
2. Patients not candidate for or had refused lung volume reduction surgery.